catechin has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abraham, DJ; Aden, N; Bruckdorfer, R; Denton, CP; Desai, N; Dooley, A; Shi-Wen, X; Tranah, T | 1 |
| Asboe-Hansen, G | 1 |
2 other study(ies) available for catechin and Sclerosis, Systemic
| Article | Year |
|---|---|
Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
Topics: Analysis of Variance; Antioxidants; Biopsy; Case-Control Studies; Catechin; Cells, Cultured; Collagen Type I; Extracellular Matrix; Female; Fibroblasts; Fibronectins; Humans; Reactive Oxygen Species; Scleroderma, Systemic | 2010 |
Treatment of generalized scleroderma with inhibitors of collagen synthesis.
Topics: Catechin; Chlorpromazine; Collagen; Dextrothyroxine; Glutamine; Humans; Hydralazine; Levodopa; Penicillamine; Penicillin G; Phenytoin; Prednisone; Scleroderma, Systemic | 1982 |